Canada’s True Leaf Medicine (tickers: CSE:MJ; OTCQB:TRLFF) received SEC approval for a Reg A+ offering, according to a news report, highlighting the wide range of companies that can benefit from the regulatory framework. The company is already listed in Canada while trading OTC in the U.S., but the Reg A+ deal could clear the way for a listing on a major U.S. exchange like Nasdaq, the company says.
Canadian Cannabis Company Gets SEC Approval for Reg A+ Offering in U.S.
